Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY: COR )

248.48 +0.54 (+0.22%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 672,338
Open 248.71
Bid (Size) 242.00 (1)
Ask (Size) 250.00 (1)
Prev. Close 247.94
Today's Range 247.18 - 249.19
52wk Range 214.77 - 253.27
Shares Outstanding 44,197,721
Dividend Yield 0.82%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Breaking Down Cencora: 6 Analysts Share Their Views
Via Benzinga
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60. 
Via Benzinga

Performance

YTD
+10.56%
+10.56%
1 Month
+9.66%
+9.66%
3 Month
+5.98%
+5.98%
6 Month
+9.16%
+9.16%
1 Year
+13.54%
+13.54%

More News

Read More
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Looking Into Cencora's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
(COR) - Analyzing Cencora's Short Interest
Via Benzinga
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
Looking Into Cencora's Recent Short Interest
Via Benzinga
McKesson Stock Gets A RS Rating Lift To 75
Via Investor's Business Daily
Cardinal Health Stock Sees IBD RS Rating Improve To 71
Via Investor's Business Daily
Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday?
Via Benzinga
Topics Government
Exposures Political
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
Via Benzinga
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today
Via Benzinga
Analyst Scoreboard: 6 Ratings For Cencora
Via Benzinga
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
From Cencora
Via Business Wire
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Via MarketBeat
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.